Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed)

Funding Opportunity PAR-20-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding